Bob Mahley, MD, PhD
Bob Mahley is the president emeritus and founder of Gladstone, and his research has contributed important findings to the fields of metabolism, cardiovascular disease, and neurological disease. He and his team defined the role of apolipoprotein (apo) E in cholesterol metabolism and atherosclerosis, which laid the groundwork for the explosion of research linking a variant of apoE—apoE4—to the pathogenesis of Alzheimer’s disease and other neurodegenerative disorders. Bob continues to contribute to the elucidation of the role of apoE4 in Alzheimer’s disease. In this seminar he will share his 30-year involvement in the Turkish Heart Study, through which he established a Gladstone laboratory in Istanbul.
A monthly tradition for over 25 years, Science for Admin is a forum for Gladstone scientists to share their latest research with their administrative colleagues.
Diversity, Equity, and Inclusion
At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.
We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.